AbbVie Raises Full-Year Outlook as First-Quarter Results Top Street Estimates
In This Article:
AbbVie (ABBV) lifted its full-year outlook on Friday as the biopharmaceutical company recorded first
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.